Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177980 | SCV000229947 | likely benign | not specified | 2017-04-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000767038 | SCV000568779 | likely benign | not provided | 2021-02-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22995991, 15922184, 30753492, 33570564) |
Center for Human Genetics, |
RCV000680459 | SCV000807834 | likely benign | Connective tissue disorder | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000767038 | SCV001052276 | likely benign | not provided | 2025-01-24 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000767038 | SCV001143577 | benign | not provided | 2019-07-12 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000680459 | SCV002566638 | uncertain significance | Connective tissue disorder | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000767038 | SCV004042439 | benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | COL11A1: PP3, BS1, BS2 |
Prevention |
RCV004537455 | SCV004731606 | likely benign | COL11A1-related disorder | 2021-02-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |